[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Pages 46335-46336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19109]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Almac Clinical 
Services Inc. (ACSI)

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Almac Clinical Services Inc. (ACSI) applied to be registered 
as an importer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants Almac Clinical Services 
Inc. (ACSI) registration as an importer of those controlled substances.

SUPPLEMENTARY INFORMATION:  By notice dated April 14, 2015, and 
published in the Federal Register on April 22, 2015, 80 FR 22556, Almac 
Clinical Services Inc. (ACSI), 25 Fretz Road, Souderton, Pennsylvania 
18964 applied to be registered as an importer of certain basic classes 
of controlled substances. No comments or objections were submitted for 
this notice.
    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of Almac Clinical Services 
Inc. (ACSI) to import the basic classes of controlled substances is 
consistent with the public interest and with United States obligations 
under international treaties, conventions, or protocols in effect on 
May 1, 1971. The DEA investigated the company's maintenance of 
effective controls against diversion by inspecting and testing the 
company's physical security systems, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Tapentadol (9780)..........................  II

[[Page 46336]]

 
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances in dosage form to conduct clinical trials.

    Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19109 Filed 8-3-15; 8:45 am]
BILLING CODE 4410-09-P